According to study, “World
Acetaminophen Market Research Report 2024(Covering USA, Europe, China, Japan,
SEA and India)” the key companies
operating in the Acetaminophen market are MallinckrodtPlc, FarmsonSKPL, Atabay,
Temad, AnqiuLu'an, Granules India, Zhejiang Kangle, HebeiJiheng, Novacyl, ORGANICA
Feinchemie GmbH Wolfen, Granules India, Kemcolour International, Parchem Fine
Specialty Chemicals, Jinan Haohua Industry Co. Ltd., BOC Science, Anhui
FuboreAnhui BBCA Likang, ChangshuHuagang, Haihang Industry Co. Ltd., HuzhouKonch,
Anhui Topsun, Wuxi Feipeng Imp. Exp. (Group) Co., Limited.,Angene International
Ltd., Sino Chemical. These players are using different strategies such as
merger & acquisitions, collaboration, partnership and product to hold the
considerable market stake.
Acetaminophen, commonly known as Paracetamol is the most widely used
analgesic and antipyretic that relieves pain and reduce fever. The name
‘Paracetamol’ is accepted by the International Nonproprietary, Australia and
Britain, while Acetaminophen is the name that is approved and used in U.S and
Japan. It is normally used to treat inflammatory pain (from headaches,
toothaches, menstrual periods, backaches, or cold/flu aches, osteoarthritis,
and pains) and to reduce fever. It is safe for use at recommended doses but
overdose of drug leads to nausea, vomiting and sweating. Serious skin rashes
may rarely occur, however high dose of the drug can result in liver failure. It
is classified as non-steroidal anti-inflammatory drug. Acetaminophen contains
of a benzene ring core, substituted by one hydroxyl group and the nitrogen atom
of an amide group. Some side effects are included allergic reaction, rash,
itching, dizziness, trouble breathing and others.
Acetaminophen is also available in many
over-the-counter combination medications with other drugs, such as Actifed,
Cepacol, Contac, Alka-Seltzer Plus Liquid Gels, Coridicin, Dayquil, Dimetapp,
Excedrin, Dristan, Feverall, Liquiprin, Nyquil, Panadol, Robitussin Singlet,
Midol, Sinutab, Sudafed, Triaminic, Vanquish, Theraflu, Vicks, and Zicam.
Based on product, market is segmented into less than
80, 80 to 120 and above 120. Based on application, market is segmented into
tablet, oral, granules, and others. The common adult dose is 500 to 1000 mg and
the drug is safe for all age groups including children and infants. In
addition, based on end-use industries, market is segmented into dye industries,
pharmaceuticals and chemical industries.
The market is driven by increase in demand from
pharmaceutical industries as a medicine, followed by rise in availability of
production facilities, advancement in production techniques, increase in
dominance of diseases & disorders for instance cold, swine flu, arthritis
& fever, increase in health care expenditure and rise in demand for generic
drugs. However, hazardous effects, increase in popularity of sustainable
chemistry and risk of heart attack due to high consumption of acetaminophen may
impact the market. Moreover, rise in emerging economies is a key opportunity
for market.
Based on geography, the Asian-Pacific region holds
major share in market owing to rise in availability of cheap drugs and increase
in population in the region. Acetaminophen is also widely used and prescribed
in North America and European markets. North-American and European regions are
expected to witness higher growth rate due to increase in demand from dye &
chemical industries over the forecast period. It is anticipated that the market
will be reached at US $780 million, by 2024.
For more information on the research
report, refer to below link:
Contact Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249